Jim Cramer, the host of Mad Money, said Friday that with a new round of earnings reports on the horizon, the market can ...
Dividend stocks have traditionally attracted long-term investors, but they are often overshadowed by flashy growth stocks ...
READ ALSO Jim Cramer Discussed These 16 Stocks Recently and Jim Cramer’s Latest Comments on These 17 Stocks ...
On November 6, 2025, UroGen Pharma Ltd. (NASDAQ:URGN) reported its Q3 2025 results, highlighting strong growth in demand ...
On November 10, 2025, The Fly reported that H.C. Wainwright increased its price target on Vera Therapeutics, Inc.
Janux Therapeutics, Inc. (NASDAQ: JANX) is one of the best small-cap biotech stocks to buy according to analysts.
On November 6, 2025, RBC Capital raised its price target on Viridian Therapeutics, Inc. (NASDAQ:VRDN) from $41 to $45, while ...
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025. The quarter marked continued ...
On November 12, 2025, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) saw JPMorgan reduce its price target from $40 to $33, while ...
On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a ...
On November 11, 2025, William Blair kept its “Market Perform” rating. The investment firm sees the FDA’s Complete Response ...
Ondas Holdings soared by 23.58 percent week-on-week as investors took heart from an investment firm’s bullish outlook for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback